Difference between revisions of "Team:ASIJ Tokyo"
m |
|||
| Line 3: | Line 3: | ||
<head> | <head> | ||
<title>ASIJ_Tokyo</title> | <title>ASIJ_Tokyo</title> | ||
| + | </head> | ||
<style type="text/css"> | <style type="text/css"> | ||
| Line 188: | Line 189: | ||
</style> | </style> | ||
| − | |||
<body> | <body> | ||
Revision as of 11:26, 12 October 2018
| A1-AT |
Using Stem Cell and CRISPR Technology to Combat Alpha-1 Antitrypsin Deficiency |